Skip to content

Astra’s CEO to head pharma trade group

AstraZeneca PLC's chief executive officer, David Brennan, was elected board chairman of the Pharmaceutical Research and Manufacturers of America today at the trade association's annual meeting.

AstraZeneca PLC's chief executive officer, David Brennan, was elected board chairman of the Pharmaceutical Research and Manufacturers of America today at the trade association's annual meeting.

Brennan succeeds Merck & Co. Inc. CEO Richard T. Clark.

PhRMA represents the country's largest pharmaceutical research and biotechnology companies.

AstraZeneca is based in London but has U.S. headquarters in Wilmington.    - Miriam Hill